Amicus Therapeutics to Announce Fourth Quarter and Year End 2010 Financial Results on February 14, 2011

CRANBURY, N.J., Feb. 8, 2011 /PRNewswire/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will host a conference call and live audio webcast on Monday, February 14, 2011 to discuss fourth quarter and full year 2010 financial results.

Interested participants and investors may access the conference call at 5 p.m. EST by dialing 877-303-5859 (U.S./Canada) or 678-224-7784 (international). An audio webcast can also be accessed via http://ir.amicustherapeutics.com/events.cfm.

A telephonic replay of the call will be available for seven days beginning at 8 p.m. EST. Access numbers for this replay are 800-642-1687 (U.S./Canada) and 706-645-9291 (international); participant code 43466317. The webcast replay will remain available in the Investors section of the Amicus Therapeutics Web site for 30 days.

Amicus' press releases are available at www.amicustherapeutics.com.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company focused on developing treatments for rare diseases.  The Company is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and diseases of neurodegeneration.  Amicus' lead program is in Phase 3 for the treatment of Fabry disease. 

FOLD–G

SOURCE Amicus Therapeutics